A healthy upside potential exists for G1 Therapeutics Inc (GTHX) Stock
JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]
It’s an all-out bull run for G1 Therapeutics Inc (GTHX) Stock
JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]
G1 Therapeutics Inc (GTHX) Stock Is Looking Attractive
JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]
Facts about G1 Therapeutics Inc (GTHX) Stock that you might not know
JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]
Why G1 Therapeutics Inc (NASDAQ:GTHX) Stock climbed 38.46% in Last Three Months?
JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]
What is G1 Therapeutics Inc’s (GTHX) Stock Real Technical Picture?
JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]
Analysts Estimated Revenue of $15.26M in the current quarter for G1 Therapeutics Inc (NASDAQ:GTHX) Stock
JP Morgan raised the price target for the G1 Therapeutics Inc (NASDAQ:GTHX) stock from “an Underweight” to “a Neutral”. The rating was released on January 30, 2023, according to finviz. We previously noted in another research note published on January 03, 2023 by Needham that reiterated the stock to a Buy with a price target […]
